推薦產品
生物源
mouse
品質等級
抗體表格
purified immunoglobulin
抗體產品種類
primary antibodies
無性繁殖
monoclonal
物種活性
human
製造商／商標名
Chemicon®
技術
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
同型
IgG1
運輸包裝
wet ice
特異性
Specific to HCV NS5A
免疫原
Recombinant protein to NS5A
應用
ELISA
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.
外觀
Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide
儲存和穩定性
Store at 2 to 8°C for up to 12 months from date of receipt.
法律資訊
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到適合的產品？
試用我們的產品選擇工具.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類（WGK）
WGK 2
閃點（°F）
Not applicable
閃點（°C）
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
Enhanced Ca2+ leak from ER Ca2+ stores induced by hepatitis C NS5A protein.
Lisbeth C Robinson, Jonathan S Marchant, Lisbeth C Robinson, Jonathan S Marchant
Biochemical and biophysical research communications null
Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme.
Chang Ho Lee,Ji Hyun Kim,Hee Won Kim,Heejoon Myung,Seong-Wook Lee
Nucleic Acid Therapeutics null
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee, CH; Lee, YJ; Kim, JH; Lim, JH; Kim, JH; Han, W; Lee, SH; Noh, GJ; Lee, SW
Journal of virology null
Shao-Ru Chen et al.
Molecules (Basel, Switzerland), 21(10) (2016-10-19)
Hepatitis C virus (HCV) infects 200 million people worldwide, and 75% of HCV cases progress into chronic infections, which consequently cause cirrhosis and hepatocellular carcinoma. HCV infection is treated with currently considered standard drugs, including direct anti-viral agents (DAAs), alone
Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1?.
Matsui, C; Shoji, I; Kaneda, S; Sianipar, IR; Deng, L; Hotta, H
Journal of virology null
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務